Waters Temettü

Temettü kriter kontrolleri 0/6

Waters şirketinin temettü ödeme geçmişi bulunmamaktadır.

Anahtar bilgiler

n/a

Temettü verimi

-0.1%

Geri Alım Getirisi

Toplam Hissedar Getirisi	-0.1%
Gelecekteki Temettü Verimi	0%
Temettü Büyümesi	n/a
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	n/a
Ödeme oranı	n/a

Son temettü güncellemeleri

Güncelleme yok

Recent updates

Waters Corporation's (NYSE:WAT) Business Is Yet to Catch Up With Its Share Price

May 26

Waters Corporation: Still Struggling A Bit

May 24

Estimating The Intrinsic Value Of Waters Corporation (NYSE:WAT)

Apr 25

Is It Too Late To Consider Buying Waters Corporation (NYSE:WAT)?

Apr 07

We Think Waters (NYSE:WAT) Can Stay On Top Of Its Debt

Mar 19

Waters Corporation: A Great (Share Price) Run

Mar 11

Waters Corporation (NYSE:WAT) Released Earnings Last Week And Analysts Lifted Their Price Target To US$323

Feb 09

Waters Corporation's (NYSE:WAT) Price Is Out Of Tune With Earnings

Jan 09

Waters Corporation: High Quality Niche Company In Mass Spectrometry

Dec 28

A Look At The Fair Value Of Waters Corporation (NYSE:WAT)

Dec 10

Is There Now An Opportunity In Waters Corporation (NYSE:WAT)?

Nov 25

Waters Corporation: Appealing Levels Are Offset By Weaker Performance

Nov 13

Waters (NYSE:WAT) Seems To Use Debt Quite Sensibly

Oct 26

Waters Corporation: Buybacks Ceased, Incremental Returns Languishing (Rating Downgrade)

Sep 27

What Does Waters Corporation's (NYSE:WAT) Share Price Indicate?

Aug 21

Calculating The Intrinsic Value Of Waters Corporation (NYSE:WAT)

Aug 03

Waters Corporation: Temporary Headwinds Present A Buying Opportunity

Jul 18

These 4 Measures Indicate That Waters (NYSE:WAT) Is Using Debt Reasonably Well

Jul 16

Is Now The Time To Look At Buying Waters Corporation (NYSE:WAT)?

May 23

A Look At The Intrinsic Value Of Waters Corporation (NYSE:WAT)

Apr 29

Here's Why Waters (NYSE:WAT) Can Manage Its Debt Responsibly

Apr 08

What Is Waters Corporation's (NYSE:WAT) Share Price Doing?

Feb 22

Waters Q4 2022 Earnings Preview

Feb 14

Waters Corp.: Now Best Price-Positioned Medical Services Stock

Feb 02

Waters Corporation (NYSE:WAT) Shares Could Be 31% Above Their Intrinsic Value Estimate

Jan 26

Does Waters (NYSE:WAT) Have A Healthy Balance Sheet?

Jan 05

Should You Think About Buying Waters Corporation (NYSE:WAT) Now?

Nov 24

Waters Corporation: Tactical Buy Seeking Upside Objectives Of $345, $363

Nov 16

Waters Q3 2022 Earnings Preview

Oct 31

Estimating The Fair Value Of Waters Corporation (NYSE:WAT)

Oct 19

Waters announces €6M R&D investment at Wexford facility

Oct 07

Is Waters (NYSE:WAT) Using Too Much Debt?

Oct 01

Do Waters' (NYSE:WAT) Earnings Warrant Your Attention?

Aug 23

Waters Corporation: Thesis Unchanged

Aug 18

Is There Now An Opportunity In Waters Corporation (NYSE:WAT)?

Aug 05

Waters Non-GAAP EPS of $2.75 beats by $0.08, revenue of $714M beats by $7.23M

Aug 02

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: WAT şirketinin hisse başına düşen temettülerinin geçmişte istikrarlı olup olmadığını belirlemek için yeterli veri yok.

Büyüyen Temettü: WAT şirketinin temettü ödemelerinin artıp artmadığını belirlemek için yeterli veri yok.

Piyasaya Karşı Temettü Getirisi

Waters Piyasaya Karşı Temettü Getirisi

WAT temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (WAT)	n/a
Pazarın Alt %25'i (US)	1.4%
Pazarın En İyi %25'i (US)	4.5%
Sektör Ortalaması (Life Sciences)	0.5%
Analist tahmini (WAT) (3 yıla kadar)	0%

Önemli Temettü: WAT şirketinin temettü getirisi, şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, temettü ödeyenlerin en alttaki %25'lik dilimine göre değerlendirilemiyor.

Yüksek Temettü: Şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, WAT şirketinin temettü getirisi, temettü ödeyenlerin en üst %25'ine göre değerlendirilemiyor.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: WAT şirketinin temettü ödemelerinin kazançlarla karşılanıp karşılanmadığını belirlemek için ödeme oranını hesaplamak üzere yeterli veri yok.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: WAT herhangi bir ödeme bildirmediğinden temettülerin sürdürülebilirliği hesaplanamıyor.

Waters Temettü

Temettü kriter kontrolleri 0/6

Anahtar bilgiler

Son temettü güncellemeleri

Recent updates

Price target increased by 7.5% to US$375

Second quarter 2024 earnings released: EPS: US$2.41 (vs US$2.56 in 2Q 2023)

Waters Corporation Raises Earnings Guidance for the Full Year of Fiscal Year Ending December 31, 2024

Now 20% undervalued

Waters Corporation Announces New Bioseparations Tools Accelerate and Improve Development of Rna-Based Vaccines and Therapies Using LC-MS Analysis

Waters Corporation Introduces TA Instruments Discovery Core Rheometer

Now 20% undervalued

Waters Corporation's (NYSE:WAT) Price Is Out Of Tune With Earnings

A Look At The Fair Value Of Waters Corporation (NYSE:WAT)

Waters Corp.: Embedded Expectations High Under Present Conditions

Does Waters (NYSE:WAT) Have A Healthy Balance Sheet?

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Waters Corporation to Report Q2, 2024 Results on Jul 31, 2024

Waters Corporation New Rapid Screening-DSC Enables Up to 24x Faster Thermal Stability Testing at Ultra-Low Sample Volumes for Antibody Drugs

Should You Think About Buying Waters Corporation (NYSE:WAT) Now?

Now 20% undervalued after recent price drop

Waters Corporation's (NYSE:WAT) Business Is Yet to Catch Up With Its Share Price

Waters Corporation: Still Struggling A Bit

Independent Director notifies of intention to sell stock

Waters Corporation Provides Earnings Guidance for the Second Quarter and Full Year of 2024

First quarter 2024 earnings: EPS misses analyst expectations

Estimating The Intrinsic Value Of Waters Corporation (NYSE:WAT)

Waters Corporation Accelerates the Development of Gene-Based Therapeutics with New GTxResolve Premier SEC Columns

Is It Too Late To Consider Buying Waters Corporation (NYSE:WAT)?

Waters Corporation, Annual General Meeting, May 23, 2024

We Think Waters (NYSE:WAT) Can Stay On Top Of Its Debt

Waters Corporation: A Great (Share Price) Run

Waters Corporation (NYSE:WAT) Released Earnings Last Week And Analysts Lifted Their Price Target To US$323

Price target increased by 7.8% to US$323

Waters Corporation Provides Earnings Guidance for the First Quarter and Full-Year 2024

Waters Corporation's (NYSE:WAT) Price Is Out Of Tune With Earnings

Waters Corporation: High Quality Niche Company In Mass Spectrometry

A Look At The Fair Value Of Waters Corporation (NYSE:WAT)

Is There Now An Opportunity In Waters Corporation (NYSE:WAT)?

Waters Corporation: Appealing Levels Are Offset By Weaker Performance

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Now 22% undervalued after recent price drop

Waters (NYSE:WAT) Seems To Use Debt Quite Sensibly

Waters Corporation Announces Resignation of Jonathan Pratt as Senior Vice President of the Waters Division

Waters Corporation Launched OligoWorks SPE Workflow and Kits

Waters Corporation: Buybacks Ceased, Incremental Returns Languishing (Rating Downgrade)

Waters Corporation Introduces DynaPro™? ZetaStar™? Instrument from its Wyatt Technology™? Portfolio for Nanoparticle Analysis

What Does Waters Corporation's (NYSE:WAT) Share Price Indicate?

Independent Director notifies of intention to sell stock

Waters Corporation Provides Earnings Guidance for the Third Quarter and Full Year 2023

Calculating The Intrinsic Value Of Waters Corporation (NYSE:WAT)

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Waters Corporation Launches XBridge Premier GTx BEH SEC Columns for Gene Therapy Applications

Waters Corporation: Temporary Headwinds Present A Buying Opportunity

These 4 Measures Indicate That Waters (NYSE:WAT) Is Using Debt Reasonably Well

Waters Corporation Boosts Resolution and Triples Scan Speed of Select Series MRT for Metabolomics and MS Imaging

Is Now The Time To Look At Buying Waters Corporation (NYSE:WAT)?

Price target decreased by 9.9% to US$311

Waters Corporation Provides Earnings Guidance for the Second Quarter of 2023 and Fiscal Year 2023

First quarter 2023 earnings: EPS and revenues miss analyst expectations

A Look At The Intrinsic Value Of Waters Corporation (NYSE:WAT)

Here's Why Waters (NYSE:WAT) Can Manage Its Debt Responsibly

Independent Director recently bought US$998k worth of stock

What Is Waters Corporation's (NYSE:WAT) Share Price Doing?

Waters Corporation Provides Earnings Guidance for the First Quarter of 2023 and Fiscal Year 2023

Full year 2022 earnings: Revenues and EPS in line with analyst expectations

Waters Q4 2022 Earnings Preview

Waters Corp.: Now Best Price-Positioned Medical Services Stock

Waters Corporation (NYSE:WAT) Shares Could Be 31% Above Their Intrinsic Value Estimate

Waters Corporation Announces Waters_Connect™ System Monitoring

Does Waters (NYSE:WAT) Have A Healthy Balance Sheet?

Waters Corporation Announces Executive Changes

Independent Director recently sold US$354k worth of stock

High number of new directors

Should You Think About Buying Waters Corporation (NYSE:WAT) Now?

Waters Corporation Appoints Dan Brennan and Mark Vergnano to Board of Directors

Waters Introduces New PFAS Quantitation Workflow Enabled by Enhancements to Waters_Connect Informatics Platform

Waters Corporation: Tactical Buy Seeking Upside Objectives Of $345, $363

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Waters Corporation Provides Earnings Guidance for the Fourth Quarter and Full Year of 2022